Meds Coupons

View Deals

8 Coupons

  • eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention. .
      . .

      mrs cavanagh, from foyle park in londonderry, had a complex medical history of chronic heart and renal failure. .

      on critical illness, 4.6 per cent of claims were declined due to the definition not being met and 2.3 per cent were due to misrepresentation. .

    • .

      related articles

  • . .

    for advertisers .
    .

    .

    of the life claims declined, 0.85 per cent were due to mis-representation and 0.16 per cent due to the definition of terminal illness not being met.  .

    suicidal thoughts, attempts on the rise among young people: 'it's a critical public-health crisis right now' .